Novo Nordisk

A $6-billion company headquartered in Denmark, Novo Nordisk is a world leader in the development and sale of diabetes-management, haemostasis-management, and hormone-therapy products. Novo Nordisk products are available in 179 countries (Source: novonordisk.com).

Two Novo Nordisk websites, changingdiabetes-us.com and changingdiabetes-us.com/Educators, were suffering from technical instability. The code of each was outdated, and neither was compliant with the updated Novo Nordisk brand. In addition, almost none of the groundbreaking implications of the Diabetes Attitudes Wishes & Needs (DAWN) Study, which reinforced the vital importance of increasing patient involvement in diabetes care, had been integrated into the websites. closerlook redesigned both changingdiabetes-us.com and changingdiabetes-us.com/educators, and developed tools that enhance the ability of diabetics to manage their own care.